Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-30

Clinical Trial Update: A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand [Phase 2]

View source ↗

Summary

Phase II trial of a live attenuated tetravalent dengue vaccine in healthy Thai adults has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Live attenuated tetravalent dengue vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30